Tag Archives: UCLA

Nicotine Patches, 3

Posted on December 20, 2021 by Gerald Barnett

Now for the University of California, Los Angeles. The Association of University Technology Managers (AUTM) wrote up the UC nicotine patch story with the headline “Turning Quitters Into Winners: The Nicotine Patch Success Story” as part of their “Better World … Continue reading →

Posted in Bayh-Dole, Technology Transfer | Tagged , , , | Comments Off on Nicotine Patches, 3

Xtandi demonstrates how Bayh-Dole is a do WTF you want law, 3

Posted on March 16, 2018 by Gerald Barnett

The first part of this article is here. The exclusive license that UCLA granted to Medivation meets the requirements for an assignment of the subject invention. The license grants substantially all rights in the subject invention (to all compounds for … Continue reading →

Posted in Bayh-Dole | Tagged , , , , , , | Comments Off on Xtandi demonstrates how Bayh-Dole is a do WTF you want law, 3

Xtandi demonstrates how Bayh-Dole is a do WTF you want law, 2

Posted on March 15, 2018 by Gerald Barnett

The first part of this article is here. To explore these issues, let’s take a look at Xtandi, a prostate cancer drug that has received press recently in the debate over high drug prices. Xtandi sells in the U.S. for … Continue reading →

Posted in Bayh-Dole | Tagged , , , , , , , | Comments Off on Xtandi demonstrates how Bayh-Dole is a do WTF you want law, 2

Xtandi demonstrates how Bayh-Dole is a do WTF you want law, 1

Posted on March 14, 2018 by Gerald Barnett

There is a big divide regarding what Bayh-Dole was supposed to accomplish with regard to the use of patents on publicly funded research. On one side is the view that publicly supported research should be freely or otherwise reasonably available … Continue reading →

Posted in Bayh-Dole | Tagged , , , , , , | Comments Off on Xtandi demonstrates how Bayh-Dole is a do WTF you want law, 1